188 related articles for article (PubMed ID: 15892579)
21. CYP4B1 activates 4-ipomeanol in rat lung.
Verschoyle RD; Philpot RM; Wolf CR; Dinsdale D
Toxicol Appl Pharmacol; 1993 Dec; 123(2):193-8. PubMed ID: 8248926
[TBL] [Abstract][Full Text] [Related]
22. New prodrug activation gene therapy for cancer using cytochrome P450 4B1 and 2-aminoanthracene/4-ipomeanol.
Rainov NG; Dobberstein KU; Sena-Esteves M; Herrlinger U; Kramm CM; Philpot RM; Hilton J; Chiocca EA; Breakefield XO
Hum Gene Ther; 1998 Jun; 9(9):1261-73. PubMed ID: 9650611
[TBL] [Abstract][Full Text] [Related]
23. In vitro metabolism of oxymetazoline: evidence for bioactivation to a reactive metabolite.
Mahajan MK; Uttamsingh V; Daniels JS; Gan LS; LeDuc BW; Williams DA
Drug Metab Dispos; 2011 Apr; 39(4):693-702. PubMed ID: 21177487
[TBL] [Abstract][Full Text] [Related]
24. Investigation of bioactivation of ticlopidine using linear ion trap/orbitrap mass spectrometry and an improved mass defect filtering technique.
Ruan Q; Zhu M
Chem Res Toxicol; 2010 May; 23(5):909-17. PubMed ID: 20297803
[TBL] [Abstract][Full Text] [Related]
25. Identification of a novel glutathione conjugate of flutamide in incubations with human liver microsomes.
Kang P; Dalvie D; Smith E; Zhou S; Deese A
Drug Metab Dispos; 2007 Jul; 35(7):1081-8. PubMed ID: 17403914
[TBL] [Abstract][Full Text] [Related]
26. Covalent thiol adducts arising from reactive intermediates of cocaine biotransformation.
Schneider KJ; DeCaprio AP
Chem Res Toxicol; 2013 Nov; 26(11):1755-64. PubMed ID: 24112049
[TBL] [Abstract][Full Text] [Related]
27. Glutathione trapping to measure microsomal oxidation of furan to cis-2-butene-1,4-dial.
Peterson LA; Cummings ME; Vu CC; Matter BA
Drug Metab Dispos; 2005 Oct; 33(10):1453-8. PubMed ID: 16006568
[TBL] [Abstract][Full Text] [Related]
28. Bioactivation of 6,7-dimethyl-2,4-di-1-pyrrolidinyl-7H-pyrrolo[2,3-d]pyrimidine (U-89843) to reactive intermediates that bind covalently to macromolecules and produce genotoxicity.
Zhao Z; Koeplinger KA; Padbury GE; Hauer MJ; Bundy GL; Banitt LS; Schwartz TM; Zimmermann DC; Harbach PR; Mayo JK; Aaron CS
Chem Res Toxicol; 1996 Dec; 9(8):1230-9. PubMed ID: 8951224
[TBL] [Abstract][Full Text] [Related]
29. A liquid chromatography/tandem mass spectrometry method for detecting UGT-mediated bioactivation of drugs as their N-acetylcysteine adducts in human liver microsomes.
Harada H; Endo T; Momose Y; Kusama H
Rapid Commun Mass Spectrom; 2009 Mar; 23(5):564-70. PubMed ID: 19177506
[TBL] [Abstract][Full Text] [Related]
30. Ligand characterization of CYP4B1 isoforms modified for high-level expression in Escherichia coli and HepG2 cells.
Roellecke K; Jäger VD; Gyurov VH; Kowalski JP; Mielke S; Rettie AE; Hanenberg H; Wiek C; Girhard M
Protein Eng Des Sel; 2017 Mar; 30(3):205-216. PubMed ID: 28073960
[TBL] [Abstract][Full Text] [Related]
31. Bioactivation of lamotrigine in vivo in rat and in vitro in human liver microsomes, hepatocytes, and epidermal keratinocytes: characterization of thioether conjugates by liquid chromatography/mass spectrometry and high field nuclear magnetic resonance spectroscopy.
Chen H; Grover S; Yu L; Walker G; Mutlib A
Chem Res Toxicol; 2010 Jan; 23(1):159-70. PubMed ID: 19961160
[TBL] [Abstract][Full Text] [Related]
32. Sites of covalent attachment of CYP4 enzymes to heme: evidence for microheterogeneity of P450 heme orientation.
Baer BR; Schuman JT; Campbell AP; Cheesman MJ; Nakano M; Moguilevsky N; Kunze KL; Rettie AE
Biochemistry; 2005 Oct; 44(42):13914-20. PubMed ID: 16229480
[TBL] [Abstract][Full Text] [Related]
33. 4-Ipomeanol and 2-aminoanthracene cytotoxicity in C3H/10T1/2 cells expressing rabbit cytochrome P450 4B1.
Smith PB; Tiano HF; Nesnow S; Boyd MR; Philpot RM; Langenbach R
Biochem Pharmacol; 1995 Nov; 50(10):1567-75. PubMed ID: 7503758
[TBL] [Abstract][Full Text] [Related]
34. Bioactivation of coumarin in rat olfactory mucosal microsomes: Detection of protein covalent binding and identification of reactive intermediates through analysis of glutathione adducts.
Zhuo X; Zhao W; Zheng J; Humphreys WG; Shu YZ; Zhu M
Chem Biol Interact; 2009 Oct; 181(2):227-35. PubMed ID: 19576871
[TBL] [Abstract][Full Text] [Related]
35. Evidence for the bioactivation of zomepirac and tolmetin by an oxidative pathway: identification of glutathione adducts in vitro in human liver microsomes and in vivo in rats.
Chen Q; Doss GA; Tung EC; Liu W; Tang YS; Braun MP; Didolkar V; Strauss JR; Wang RW; Stearns RA; Evans DC; Baillie TA; Tang W
Drug Metab Dispos; 2006 Jan; 34(1):145-51. PubMed ID: 16251255
[TBL] [Abstract][Full Text] [Related]
36. Inhibitory effect of dietary 4-ipomeanol on DNA adduct formation by the food mutagen 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) in male CDF1 mice.
Cummings DA; Schut HA
Carcinogenesis; 1995 Oct; 16(10):2523-9. PubMed ID: 7586161
[TBL] [Abstract][Full Text] [Related]
37. Mechanism-based inactivation of human recombinant P450 2C9 by the nonsteroidal anti-inflammatory drug suprofen.
O'Donnell JP; Dalvie DK; Kalgutkar AS; Obach RS
Drug Metab Dispos; 2003 Nov; 31(11):1369-77. PubMed ID: 14570769
[TBL] [Abstract][Full Text] [Related]
38. The relationship between the catalytic activities of rabbit pulmonary cytochrome P-450 isozymes and the lung-specific toxicity of the furan derivative, 4-ipomeanol.
Wolf CR; Statham CN; McMenamin MG; Bend JR; Boyd MR; Philpot RM
Mol Pharmacol; 1982 Nov; 22(3):738-44. PubMed ID: 7155130
[TBL] [Abstract][Full Text] [Related]
39. Metabolism of 3-methylindole by vaccinia-expressed P450 enzymes: correlation of 3-methyleneindolenine formation and protein-binding.
Thornton-Manning J; Appleton ML; Gonzalez FJ; Yost GS
J Pharmacol Exp Ther; 1996 Jan; 276(1):21-9. PubMed ID: 8558432
[TBL] [Abstract][Full Text] [Related]
40. A transgenic mouse expressing human CYP4B1 in the liver.
Imaoka S; Hayashi K; Hiroi T; Yabusaki Y; Kamataki T; Funae Y
Biochem Biophys Res Commun; 2001 Jun; 284(3):757-62. PubMed ID: 11396967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
